2022-11771. Proposed Data Collection Submitted for Public Comment and Recommendations  

  • Start Preamble

    AGENCY:

    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION:

    Notice with comment period.

    SUMMARY:

    The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Enhanced surveillance of respiratory illness among people experiencing homelessness in Anchorage, Alaska. This project will entail collecting nasopharyngeal swabs from people experiencing respiratory symptoms who are accessing homeless services at congregate and non-congregate shelters in Anchorage, Alaska.

    DATES:

    CDC must receive written comments on or before August 1, 2022.

    ADDRESSES:

    You may submit comments, identified by Docket No. CDC-2022-0073 by either of the following methods:

    Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments.

    Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329.

    Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; Email: omb@cdc.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.

    The OMB is particularly interested in comments that will help:

    1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

    2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

    3. Enhance the quality, utility, and clarity of the information to be collected;

    4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and

    5. Assess information collection costs.

    Proposed Project

    Enhanced surveillance of Respiratory Illness Among People Experiencing Homelessness in Anchorage, Alaska—New—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

    Background and Brief Description

    People experiencing homelessness are at risk for respiratory infectious diseases. This project involves enhanced surveillance for respiratory viruses in congregate and non-congregate homeless shelters to provide evidence to improve public health for people who are experiencing homelessness in Anchorage, Alaska. The project team will collect an upper respiratory specimen ( e.g. nasopharyngeal swab) from people experiencing respiratory symptoms who are accessing shelters. The project team will complete a short symptom questionnaire with the participant and then conduct a medical record review to ascertain the clinical course of infection. Swabs will be tested for multiple viral pathogens to estimate the burden of pathogen-specific respiratory infections among people experiencing homelessness.

    CDC requests OMB approval for an estimated 500 annual burden hours. There is no cost to respondents other than their time to participate.

    Estimated Annualized Burden Hours

    Type of respondentsForm nameNumber of respondentsNumber of responses per respondentAverage burden per response (in hours)Total burden (in hours)
    Persons with Respiratory Symptoms Experiencing HomelessnessEnrollment in Symptom Screening1,000130/60500
    Total500
    Start Signature
    Start Printed Page 33491

    Jeffrey M. Zirger,

    Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.

    End Signature End Supplemental Information

    [FR Doc. 2022-11771 Filed 6-1-22; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Published:
06/02/2022
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Action:
Notice with comment period.
Document Number:
2022-11771
Dates:
CDC must receive written comments on or before August 1, 2022.
Pages:
33490-33491 (2 pages)
Docket Numbers:
60Day-22-22FT, Docket No. CDC-2022-0073
PDF File:
2022-11771.pdf